From Casetext: Smarter Legal Research

In re Generic Pharm. Pricing Antitrust Litig.

United States District Court, E.D. Pennsylvania
Dec 3, 2024
MDL 2724 16-md-2724 (E.D. Pa. Dec. 3, 2024)

Opinion

MDL 2724 16-md-2724 EPP 16-CB-27242 16-CM-27242

12-03-2024

IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION IN RE: CLOBETASOL CASES IN RE: CLOMIPRAMINE CASES THIS DOCUMENT APPLIES TO: EPP BELLWETHER ACTIONS


ORDER

CYNTHIA M. RUFE, JUDGE

AND NOW, this 3rd day of December 2024, upon consideration of the Motions to Exclude [16-CM-27242: Doc. Nos. 191,192, 193, 194, 214, 215, 216, 217, 253, and 256; 16-CB-27242: Doc. Nos. 246, 247, 248, 249, 272, 273, 274, 278, 316, and 325] and the responses and replies thereto, and after hearings and arguments held on September 24-26, October 8, and October 10, 2024, and for the reasons set forth in the accompanying Opinion, it is hereby ORDERED that:

1. EPPs' motions to partially exclude the opinions of Dr. James W. Hughes, Dr. Erin E. Trish, and Dr. Laura E. Happe are GRANTED.

2. EPPS' motion to partially exclude Dr. Richard J. Gilbert's opinions is GRANTED in part to exclude the opinions set forth in section IV.H of his report.

3. Defendants' motion to exclude the opinions of Dr. James T. McClave, Dr. Russell L. Lamb, Ms. Laura R. Craft, and Mr. Eric J. Miller are DENIED.

It is so ORDERED.


Summaries of

In re Generic Pharm. Pricing Antitrust Litig.

United States District Court, E.D. Pennsylvania
Dec 3, 2024
MDL 2724 16-md-2724 (E.D. Pa. Dec. 3, 2024)
Case details for

In re Generic Pharm. Pricing Antitrust Litig.

Case Details

Full title:IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION IN RE…

Court:United States District Court, E.D. Pennsylvania

Date published: Dec 3, 2024

Citations

MDL 2724 16-md-2724 (E.D. Pa. Dec. 3, 2024)